Similarly, lowering GSK-3β activity increased p53 function in colorectal cancer cells linked to apoptosis and tumor suppression [45], while GSK-3β-mediated phosphorylation of Mdm2, a protein required for p53 degradation, triggered the rapid degradation of p53 [53]. Here, MDM2 is linked to colorectal cancer.